DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ( ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

According to the team’s results, the BrainGate array wired directly to motor neurons offered a “sixfold improvement” on the ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

Cancer and its associated treatments represent a multifaceted challenge that affects both the physical and psychological well-being of patients. Over the ...

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

Women's health experts explain why so many women have been using cycle syncing to optimize wellness at every phase of the month.

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...